Rebecca Chambers
Director of Finance/CFO chez VERACYTE, INC.
Fortune : 4 M $ au 29/02/2024
Profil
Rebecca Chambers occupies the position of Chief Financial Officer at Veracyte, Inc. Ms. Chambers is also on the board of Inari Medical, Inc.
In the past she held the position of Chief Financial Officer at Outset Medical, Inc., VP-Finance, Investor Relations & Treasury at Illumina, Inc., Director-Investor Relations & Communications at Myriad Genetics, Inc., Senior Research Associate for Millennium Pharmaceuticals, Inc. and Senior Manager-Investor Relations at Life Technologies Corp.
She received an undergraduate degree from John Carroll University and an MBA from Johnson Graduate School of Management.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
VERACYTE INC
0,19% | 15/03/2024 | 146 702 ( 0,19% ) | 3 M $ | 29/02/2024 |
INARI MEDICAL, INC.
0,01% | 18/05/2023 | 6 782 ( 0,01% ) | 312 786 $ | 29/02/2024 |
Postes actifs de Rebecca Chambers
Sociétés | Poste | Début |
---|---|---|
INARI MEDICAL, INC. | Director/Board Member | 21/06/2021 |
VERACYTE, INC. | Director of Finance/CFO | 19/07/2021 |
Anciens postes connus de Rebecca Chambers
Sociétés | Poste | Fin |
---|---|---|
OUTSET MEDICAL, INC. | Director of Finance/CFO | 16/07/2021 |
MYRIAD GENETICS, INC. | Investor Relations Contact | 01/10/2012 |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Public Communications Contact | 01/12/2010 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
ILLUMINA, INC. | Investor Relations Contact | - |
Formation de Rebecca Chambers
John Carroll University | Undergraduate Degree |
Johnson Graduate School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
MYRIAD GENETICS, INC. | Health Technology |
ILLUMINA, INC. | Health Technology |
VERACYTE, INC. | Health Technology |
OUTSET MEDICAL, INC. | Health Technology |
INARI MEDICAL, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |